Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
Nature Medicine, Published online: 21 October 2026; doi:10.1038/s41591-026-04747-2 Author Correction: Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
We haven't written up this one. Nature Medicine has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
